Search Results - "Donath, M J"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII by LENTING, P. J, DONATH, M.-J. S. H, VAN MOURIK, J. A, MERTENS, K

    Published in The Journal of biological chemistry (11-03-1994)
    “…The interaction between human factor IXa and factor VIII or its constituent units was investigated. Equilibrium binding studies were performed employing factor…”
    Get full text
    Journal Article
  2. 2

    Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity by Mertens, K, Donath, M J, van Leen, R W, de Keyzer-Nellen, M J, Verbeet, M P, Klaasse Bos, J M, Leyte, A, van Mourik, J A

    Published in British journal of haematology (01-09-1993)
    “…Recombinant factor VIII variants with overlapping deletions spanning the region Lys713-Ile1668 have been expressed in mammalian cells, and analysed for…”
    Get more information
    Journal Article
  3. 3

    Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa by Donath, M J, de Laaf, R T, Biessels, P T, Lenting, P J, van de Loo, J W, van Mourik, J A, Voorberg, J, Mertens, K

    Published in Biochemical journal (15-11-1995)
    “…A factor VIII variant has been characterized in which the heavy chain is directly fused to the light chain. Des-(741-1668)-factor VIII lacks the processing…”
    Get full text
    Journal Article
  4. 4

    Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme (∗) by Lenting, Peter J., ter Maat, Hans, Clijsters, Patrick P.F.M., Donath, Marie-José S.H., van Mourik, Jan A., Mertens, Koen

    Published in The Journal of biological chemistry (23-06-1995)
    “…The transition of the factor IX zymogen into the enzyme factor IXaβ was investigated. For this purpose, the activation intermediate factors IXα and IXaα were…”
    Get full text
    Journal Article
  5. 5

    Enhanced Thrombin Sensitivity of a Factor VIII-Heparin Cofactor II Hybrid by Voorberg, J, van Stempvoort, G, Bos, J M, Mertens, K, van Mourik, J A, Donath, M J

    Published in The Journal of biological chemistry (30-08-1996)
    “…Generation of thrombin at a site of vascular injury is a key event in the arrest of bleeding. In addition to the conversion of fibrinogen into the insoluble…”
    Get full text
    Journal Article
  6. 6

    The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX by Lenting, P J, van de Loo, J W, Donath, M J, van Mourik, J A, Mertens, K

    Published in The Journal of biological chemistry (26-01-1996)
    “…In previous studies have shown that the interaction between factor IXa and VIII involves the light chain of factor VIII and that this interaction inhibited by…”
    Get full text
    Journal Article
  7. 7

    Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740 by Donath, M J, Lenting, P J, Van Mourik, J A, Mertens, K

    Published in European journal of biochemistry (01-09-1996)
    “…Activation and limited proteolysis of factor VIII have been investigated with respect to the role of the heavy-chain region Lys713-Arg740. The kinetics of…”
    Get full text
    Journal Article
  8. 8

    Transcriptional regulation of retinoic acid receptor beta in retinoic acid-sensitive and -resistant P19 embryocarcinoma cells by Kruyt, F A, van den Brink, C E, Defize, L H, Donath, M J, Kastner, P, Kruijer, W, Chambon, P, van der Saag, P T

    Published in Mechanisms of development (01-03-1991)
    “…As in other embryocarcinoma (EC) cell lines retinoic acid (RA) rapidly induces expression of the nuclear retinoic acid receptor (RAR) beta in murine P19 EC…”
    Get more information
    Journal Article